Differentiating reactive mesothelial cells from metastatic adenocarcinoma in serous effusions: the utility of immunocytochemical panel in the differential diagnosis.

Differentiating reactive mesothelial cells from metastatic adenocarcinoma in serous effusions: the utility of immunocytochemical panel in the differential diagnosis.

Item
http://www.wikidata.org/entity/Q51841556
Culture and Drug Profiling of Patient Derived Malignant Pleural Effusions for Personalized Cancer MedicineAuthors attain comparable or slightly higher rates of citation publishing in an open access journal (CytoJournal) compared to traditional cytopathology journals - A five year (2007-2011) experience.Diagnostic accuracy of Ber-EP4 for metastatic adenocarcinoma in serous effusions: a meta-analysis.A fine decision tree consisted of CK5/6, IMP3 and TTF1 for cytological diagnosis among reactive mesothelial cells, metastatic adenocarcinoma of lung and non-lung origin in pleural effusionEZH2, a unique marker of malignancy in effusion cytology.Diagnostic accuracy of MOC-31 for malignant effusions: a meta-analysis.Diagnostic accuracy of calretinin for malignant mesothelioma in serous effusions: a meta-analysis.The importance of EZH2 and MOC-31 expression in the differential diagnosis of benign and malignant effusions.Evaluation of the sensitivity and specificity of immunohistochemical markers in the differential diagnosis of effusion cytology.Adenocarcinoma cells in effusion cytology as a diagnostic pitfall with potential impact on clinical management: a case report with brief review of immunomarkers.Utility of immunochemistry in cytology.Diagnostic value of E-cadherin and fibronectin in differentiation between reactive mesothelial and adenocarcinoma cells in serous effusions.Validating Micronucleus Score in Effusion Fluids.Use of the monoclonal antibody MOC-31 as an immunomarker for detecting metastatic adenocarcinoma in effusion cytology.Immunocytochemical utility of claudin-4 versus those of Ber-EP4 and MOC-31 in effusion cytology.
P2860

Differentiating reactive mesothelial cells from metastatic adenocarcinoma in serous effusions: the utility of immunocytochemical panel in the differential diagnosis.

Item
http://www.wikidata.org/entity/Q51841556
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Differentiating reactive mesot ...... in the differential diagnosis.
@en
Differentiating reactive mesot ...... in the differential diagnosis.
@nl
type
label
Differentiating reactive mesot ...... in the differential diagnosis.
@en
Differentiating reactive mesot ...... in the differential diagnosis.
@nl
prefLabel
Differentiating reactive mesot ...... in the differential diagnosis.
@en
Differentiating reactive mesot ...... in the differential diagnosis.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Differentiating reactive mesot ...... in the differential diagnosis.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921